HALOZYME THERAPEUTICS, INC.

Lobbying client · California · filed 2025 to 2026

U.S. Biotechnology Company

$390,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (196647), not by name.

Firms hired 1

FORBES-TATE $390,000 6 filings

Reported by year 2 years

2026 $150,000 2 filings
2025 $240,000 4 filings

Issues lobbied 2

Health Issues 6
Medicare/Medicaid 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Centers For Medicare and Medicaid Services (CMS) 6
Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 6 total

Q2

FORBES-TATE

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000 income · posted Jul 20, 2026

View → Q1

FORBES-TATE

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $70,000 income · posted Apr 18, 2026

View → Q4

FORBES-TATE

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 18, 2026

View → Q3

FORBES-TATE

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 18, 2025

View → Q2

FORBES-TATE

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 18, 2025

View → Q1

FORBES-TATE

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $60,000 income · posted Apr 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.